Fluorine in anti-HIV drugs approved by FDA from 1981 to 2023

S Han, Y Lu - European Journal of Medicinal Chemistry, 2023 - Elsevier
Human immunodeficiency virus (HIV) is the etiological agent of acquired immunodeficiency
syndrome (AIDS). Nowadays, FDA has approved over thirty antiretroviral drugs grouped in …

Structural biology of HIV integrase strand transfer inhibitors

IK Jóźwik, DO Passos, D Lyumkis - Trends in pharmacological sciences, 2020 - cell.com
Integrase (IN) strand transfer inhibitors (INSTIs) are recent compounds in the antiretroviral
arsenal used against HIV. INSTIs work by blocking retroviral integration; an essential step in …

Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort …

A Trickey, K McGinnis, MJ Gill, S Abgrall… - The Lancet …, 2024 - thelancet.com
Background Mortality rates among people with HIV have fallen since 1996 following the
widespread availability of effective antiretroviral therapy (ART). Patterns of cause-specific …

Associations of modern initial antiretroviral drug regimens with all-cause mortality in adults with HIV in Europe and North America: a cohort study

A Trickey, L Zhang, MJ Gill, F Bonnet, G Burkholder… - The Lancet …, 2022 - thelancet.com
Background Over the past decade, antiretroviral therapy (ART) regimens that include
integrase strand inhibitors (INSTIs) have become the most commonly used for people with …

Outcomes after switching to BIC/FTC/TAF in patients with virological failure to protease inhibitors or non-nucleoside reverse transcriptase inhibitors: a real-world cohort …

HM Chang, PY Chou, CH Chou… - Infection and Drug …, 2021 - Taylor & Francis
Purpose This study evaluated the real-world tolerability and treatment effectiveness of
BIC/FTC/TAF in treatment-experienced patients living with HIV-1 in Taiwan, especially in …

Going beyond integration: The emerging role of HIV-1 integrase in virion morphogenesis

JL Elliott, SB Kutluay - Viruses, 2020 - mdpi.com
The HIV-1 integrase enzyme (IN) plays a critical role in the viral life cycle by integrating the
reverse-transcribed viral DNA into the host chromosome. This function of IN has been well …

Use of integrase inhibitors in HIV-associated tuberculosis in high-burden settings: implementation challenges and research gaps

A Naidoo, K Naidoo, N Padayatchi, KE Dooley - The Lancet HIV, 2022 - thelancet.com
People living with HIV have a higher risk of developing tuberculosis, and tuberculosis is one
of the leading causes of death among people living with HIV globally. Treating HIV and …

Evaluation of integrase resistance in individuals who failed a regimen containing dolutegravir in French and Italian clinical settings

D Armenia, MM Santoro, C Charpentier… - Journal of …, 2023 - academic.oup.com
Background This work aims to evaluate integrase resistance and its predictors in HIV-1
infected combined antiretroviral therapy (cART) experienced individuals failing a …

Impact of Integrase Sequences from HIV-1 Subtypes A6/A1 on the In Vitro Potency of Cabotegravir or Rilpivirine

JL Jeffrey, M St. Clair, P Wang, C Wang… - Antimicrobial Agents …, 2022 - Am Soc Microbiol
The FLAIR study demonstrated noninferiority of monthly long-acting cabotegravir+ rilpivirine
versus daily oral dolutegravir/abacavir/lamivudine for maintaining virologic suppression …

Genetic features of HIV-1 integrase sub-subtype A6 predominant in Russia and predicted susceptibility to INSTIs

A Kirichenko, I Lapovok, P Baryshev… - Viruses, 2020 - mdpi.com
The increasing use of the integrase strand transfer inhibitor (INSTI) class for the treatment of
HIV-infection has pointed to the importance of analyzing the features of HIV-1 subtypes for …